Company page

Seikagaku Corporation

Seikagaku Corporation, traded under the ticker 4548, is a public company based in Japan with a market capitalization of approximately 249 million USD. The company specializes in the development and commercialization of pharmaceuticals, particularly in the field of regenerative medicine and osteoarthritis treatment. Seikagaku is focused on advancing its innovative therapies to improve patient outcomes.